APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Decongestant

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173982730331 December 2025182 pages

Choose your research edition.

Industry ResearchDecongestant Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Decongestant Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decongestant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Decongestant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Decongestant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Decongestant include Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Ranbaxy Laboratories Ltd., Cipla Ltd. and Beximco Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Decongestant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decongestant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decongestant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Decongestant market size, projected growth trends, production technologies, key applications, and end-use industries.

Decongestant Segment by Company

Teva Pharmaceutical Industries Ltd.

Novartis AG

Mylan N.V.

Ranbaxy Laboratories Ltd.

Cipla Ltd.

Beximco Pharmaceuticals Ltd.

Decongestant Segment by Type

Nasal Sprays

Capsules

Tablets

Decongestant Segment by Application

Research & Academic Laboratories

Hospitals

Clinic

Other

Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Decongestant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Decongestant Industry Trends Table 2. Decongestant Industry Drivers Table 3. Decongestant Industry Opportunities and Challenges Table 4. Decongestant Industry Restraints Table 5. Global Decongestant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Decongestant Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Decongestant Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Decongestant Sales Market Share by Manufacturers Table 9. Global Decongestant Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Decongestant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Decongestant Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Decongestant Manufacturers, Product Type & Application Table 13. Global Decongestant Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Decongestant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nasal Sprays Table 17. Major Manufacturers of Capsules Table 18. Major Manufacturers of Tablets Table 19. Global Decongestant Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Decongestant Sales by Type (2021-2026) & (K Units) Table 21. Global Decongestant Sales by Type (2027-2032) & (K Units) Table 22. Global Decongestant Sales Market Share by Type (2021-2026) Table 23. Global Decongestant Sales Market Share by Type (2027-2032) Table 24. Global Decongestant Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Decongestant Revenue by Type (2021-2026) & (K Units) Table 26. Global Decongestant Revenue by Type (2027-2032) & (K Units) Table 27. Global Decongestant Revenue Market Share by Type (2021-2026) Table 28. Global Decongestant Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Research & Academic Laboratories Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global Decongestant Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Decongestant Sales by Application (2021-2026) & (K Units) Table 35. Global Decongestant Sales by Application (2027-2032) & (K Units) Table 36. Global Decongestant Sales Market Share by Application (2021-2026) Table 37. Global Decongestant Sales Market Share by Application (2027-2032) Table 38. Global Decongestant Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Decongestant Revenue by Application (2021-2026) & (K Units) Table 40. Global Decongestant Revenue by Application (2027-2032) & (K Units) Table 41. Global Decongestant Revenue Market Share by Application (2021-2026) Table 42. Global Decongestant Revenue Market Share by Application (2027-2032) Table 43. Global Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Decongestant Sales by Region (2021-2026) & (K Units) Table 45. Global Decongestant Sales Market Share by Region (2021-2026) Table 46. Global Decongestant Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Decongestant Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Decongestant Sales by Country (2021-2026) & (K Units) Table 50. North America Decongestant Sales by Country (2027-2032) & (K Units) Table 51. Europe Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Decongestant Sales by Country (2021-2026) & (K Units) Table 53. Europe Decongestant Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Decongestant Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Decongestant Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Decongestant Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Decongestant Sales by Country (2027-2032) & (K Units) Table 60. Global Decongestant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Decongestant Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Decongestant Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Decongestant Revenue Market Share by Region (2021-2026) Table 64. Global Decongestant Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceutical Industries Ltd. Company Information Table 66. Teva Pharmaceutical Industries Ltd. Business Overview Table 67. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio Table 69. Teva Pharmaceutical Industries Ltd. Recent Development Table 70. Novartis AG Company Information Table 71. Novartis AG Business Overview Table 72. Novartis AG Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novartis AG Decongestant Product Portfolio Table 74. Novartis AG Recent Development Table 75. Mylan N.V. Company Information Table 76. Mylan N.V. Business Overview Table 77. Mylan N.V. Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mylan N.V. Decongestant Product Portfolio Table 79. Mylan N.V. Recent Development Table 80. Ranbaxy Laboratories Ltd. Company Information Table 81. Ranbaxy Laboratories Ltd. Business Overview Table 82. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Ranbaxy Laboratories Ltd. Decongestant Product Portfolio Table 84. Ranbaxy Laboratories Ltd. Recent Development Table 85. Cipla Ltd. Company Information Table 86. Cipla Ltd. Business Overview Table 87. Cipla Ltd. Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cipla Ltd. Decongestant Product Portfolio Table 89. Cipla Ltd. Recent Development Table 90. Beximco Pharmaceuticals Ltd. Company Information Table 91. Beximco Pharmaceuticals Ltd. Business Overview Table 92. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio Table 94. Beximco Pharmaceuticals Ltd. Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Decongestant Distributors List Table 98. Decongestant Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Decongestant Product Image Figure 2. Global Decongestant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decongestant Market Size (2021-2032) & (US$ Million) Figure 4. Global Decongestant Sales (2021-2032) & (K Units) Figure 5. Global Decongestant Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Decongestant Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nasal Sprays Image Figure 9. Capsules Image Figure 10. Tablets Image Figure 11. Global Decongestant Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Decongestant Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Decongestant Sales Market Share by Type (2021-2032) Figure 14. Global Decongestant Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Decongestant Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Decongestant Revenue Market Share by Type (2021-2032) Figure 17. Research & Academic Laboratories Image Figure 18. Hospitals Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Decongestant Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Decongestant Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Decongestant Sales Market Share by Application (2021-2032) Figure 24. Global Decongestant Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Decongestant Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Decongestant Revenue Market Share by Application (2021-2032) Figure 27. North America Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Decongestant Sales Market Share by Country (2021-2032) Figure 29. U.S. Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Decongestant Sales Market Share by Country (2021-2032) Figure 34. Germany Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Decongestant Sales Market Share by Country (2021-2032) Figure 41. China Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Decongestant Sales Market Share by Country (2021-2032) Figure 49. Brazil Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Decongestant Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Decongestant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Decongestant Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Decongestant Revenue (2021-2032) & (US$ Million) Figure 60. North America Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Decongestant Revenue (2021-2032) & (US$ Million) Figure 62. Europe Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Decongestant Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Decongestant Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Decongestant Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Decongestant Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Sprays
  • Capsules
  • Tablets
Applications
  • Research & Academic Laboratories
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Ranbaxy Laboratories Ltd.
  • Cipla Ltd.
  • Beximco Pharmaceuticals Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Decongestant Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Decongestant Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Decongestant Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Decongestant Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Decongestant Market Dynamics
  1. 2.1 Decongestant Industry Trends
  2. 2.2 Decongestant Industry Drivers
  3. 2.3 Decongestant Industry Opportunities and Challenges
  4. 2.4 Decongestant Industry Restraints
3 Decongestant Market by Manufacturers
  1. 3.1 Global Decongestant Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Decongestant Sales by Manufacturers (2021-2026)
  3. 3.3 Global Decongestant Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Decongestant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Decongestant Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Decongestant Manufacturers, Product Type & Application
  7. 3.7 Global Decongestant Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Decongestant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Decongestant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Decongestant Tier 1, Tier 2, and Tier 3
4 Decongestant Market by Type
  1. 4.1 Decongestant Type Introduction
  2. 4.1.1 Nasal Sprays
  3. 4.1.2 Capsules
  4. 4.1.3 Tablets
  5. 4.2 Global Decongestant Sales by Type
  6. 4.2.1 Global Decongestant Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Decongestant Sales by Type (2021-2032)
  8. 4.2.3 Global Decongestant Sales Market Share by Type (2021-2032)
  9. 4.3 Global Decongestant Revenue by Type
  10. 4.3.1 Global Decongestant Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Decongestant Revenue by Type (2021-2032)
  12. 4.3.3 Global Decongestant Revenue Market Share by Type (2021-2032)
5 Decongestant Market by Application
  1. 5.1 Decongestant Application Introduction
  2. 5.1.1 Research & Academic Laboratories
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Decongestant Sales by Application
  7. 5.2.1 Global Decongestant Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Decongestant Sales by Application (2021-2032)
  9. 5.2.3 Global Decongestant Sales Market Share by Application (2021-2032)
  10. 5.3 Global Decongestant Revenue by Application
  11. 5.3.1 Global Decongestant Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Decongestant Revenue by Application (2021-2032)
  13. 5.3.3 Global Decongestant Revenue Market Share by Application (2021-2032)
6 Global Decongestant Sales by Region
  1. 6.1 Global Decongestant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decongestant Sales by Region (2021-2032)
  3. 6.2.1 Global Decongestant Sales by Region (2021-2026)
  4. 6.2.2 Global Decongestant Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Decongestant Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Decongestant Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Decongestant Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Decongestant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Decongestant Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Decongestant Revenue by Region
  1. 7.1 Global Decongestant Revenue by Region
  2. 7.1.1 Global Decongestant Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Decongestant Revenue by Region (2021-2026)
  4. 7.1.3 Global Decongestant Revenue by Region (2027-2032)
  5. 7.1.4 Global Decongestant Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Decongestant Revenue (2021-2032)
  8. 7.2.2 North America Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Decongestant Revenue (2021-2032)
  11. 7.3.2 Europe Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Decongestant Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Decongestant Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Decongestant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd.
  2. 8.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Decongestant Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Mylan N.V.
  14. 8.3.1 Mylan N.V. Company Information
  15. 8.3.2 Mylan N.V. Business Overview
  16. 8.3.3 Mylan N.V. Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan N.V. Decongestant Product Portfolio
  18. 8.3.5 Mylan N.V. Recent Developments
  19. 8.4 Ranbaxy Laboratories Ltd.
  20. 8.4.1 Ranbaxy Laboratories Ltd. Company Information
  21. 8.4.2 Ranbaxy Laboratories Ltd. Business Overview
  22. 8.4.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
  24. 8.4.5 Ranbaxy Laboratories Ltd. Recent Developments
  25. 8.5 Cipla Ltd.
  26. 8.5.1 Cipla Ltd. Company Information
  27. 8.5.2 Cipla Ltd. Business Overview
  28. 8.5.3 Cipla Ltd. Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cipla Ltd. Decongestant Product Portfolio
  30. 8.5.5 Cipla Ltd. Recent Developments
  31. 8.6 Beximco Pharmaceuticals Ltd.
  32. 8.6.1 Beximco Pharmaceuticals Ltd. Company Information
  33. 8.6.2 Beximco Pharmaceuticals Ltd. Business Overview
  34. 8.6.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
  36. 8.6.5 Beximco Pharmaceuticals Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Decongestant Value Chain Analysis
  2. 9.1.1 Decongestant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Decongestant Production Mode & Process
  6. 9.2 Decongestant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Decongestant Distributors
  9. 9.2.3 Decongestant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst